Figures & data
Table 1. miRNA associated with hypertension
Table 2. lncRNA associated with hypertension
Liu K, YING Z, QI X, et al. MicroRNA-1 regulates the proliferation of vascular smooth muscle cells by targeting insulin-like growth factor 1. Int J Mol Med. 2015;36(3):817–824. Zhang W-F, Zhu, T. T., Xiong, Y. W., et al. Negative feedback regulation between microRNA let-7g and LOX-1 mediated hypoxia-induced PASMCs proliferation. Biochem Biophys Res Commun. 2017;488(4):655–663. Zhang B, Yao, Y., Sun, Q. F., et al. Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease. Biosci Rep. 2017;37 (2):1–10. Carr G, Barrese V, Stott JB, et al. MicroRNA-153 targeting of KCNQ4 contributes to vascular dysfunction in hypertension. Cardiovasc Res. 2016;112(2):581–589. Liu Y, Liu G, Zhang H, et al. MiRNA-199a-5p influences pulmonary artery hypertension via downregulating Smad3. Biochem Biophys Res Commun. 2016;473(4):859–866. Yang F, Li H, Du Y, et al. Downregulation of microRNA‑34b is responsible for the elevation of blood pressure in spontaneously hypertensive rats. Mol Med Rep. 2017;15(3):1031–1036. Huber LC, Ulrich, S., Leuenberger, C., et al. Featured article: microRNA-125a in pulmonary hypertension: regulator of a proliferative phenotype of endothelial cells. Exp Biol Med. 2015;240(12):1580–1589. Kang B-Y, Park KK, Kleinhenz JM, et al. Peroxisome proliferator–activated receptor γ and microRNA 98 in hypoxia-induced endothelin-1 signaling. Am J Respir Cell Mol Biol. 2016;54(1):136–146. Jin Y, Pang T, Nelin LD, et al. MKP‐1 is a target of miR‐210 and mediate the negative regulation of miR‐210 inhibitor on hypoxic hPASMC proliferation. Cell Biol Int. 2015;39(1):113–120. Xing Y, Zheng X, Li G, et al. MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression. Int J Biochem Cell Biol. 2015;64:155–166. Wang Y-N-Z, Shan K, Yao M-D, et al. Long noncoding RNA-GAS5: a novel regulator of hypertension-induced vascular remodeling. Hypertension. 2016;68(3):736–748. Zhang X, Yang X, Lin Y, et al. Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension. Int J Clin Exp Pathol. 2015;8(6):6981. Gopalakrishnan K, Kumarasamy S, Mell B, et al. Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease. Hypertension. 2015;65(1):200–210. Michalik KM, You, X., Manavski, Y., et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014;114(9):1389–1397. Bayoglu B, Yuksel H, Cakmak HA, et al. Polymorphisms in the long non-coding RNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients. Clin Biochem. 2016;49(10–11):821–827. Wu Y-X, Zhang S-H, Cui J, et al. Long noncoding RNA XR007793 regulates proliferation and migration of vascular smooth muscle cell via suppressing miR-23b. Med Sci Monit. 2018;24:5895. Su H, Xu X, Yan C, et al. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT 1 R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension. Respir Res. 2018;19(1):254. Jin L, Lin, X., Yang, L., et al. AK098656, a novel vascular smooth muscle cell–dominant long noncoding RNA, promotes hypertension. Hypertension. 2018;71(2):262–272.